OptiBiotix Signs Major Supply Agreement for its Microbiome Modulating Cholesterol-Reduction Probiotic

d6d4fdd0-bcf5-4480-8f73-4ee148db27dbarticleimage.jpg

19 Jun 2017 --- Life sciences company OptiBiotix has signed a three-year supply agreement with HLH BioPharma Vertriebs GmbH for its cholesterol-reducing LPLDL probiotic supplement. Research into the LPLDL probiotic, presented at Vitafoods Europe in May 2017, demonstrated that it is a safe natural ingredient which reduces blood pressure and cholesterol, key determinates of cardiovascular risk. 

According to the company, the probiotic was found to reduce LDL cholesterol by up to 13.9%, and blood pressure by 5.1%. This research was carried out by Glenn Gibson, Professor of Food Microbiology, Head of Food Microbial Sciences at University of Reading.

Stephen O’Hara, CEO of OptiBiotix, comments, “The development of our LPLDL probiotic product has made cholesterol reduction through microbiome modulation a reality, and we are thrilled to be working with HLH, one of Europe’s leading suppliers to the pharmacy market, on this product. The ability to create designer active ingredients which can modify an individual’s microbiome to improve health places OptiBiotix at the forefront of global microbiome research and product development, and we anticipate many more opportunities for the LPLDL probiotic.”

Microbiome modulators in the form of probiotic supplements, like LPLDL, may be the way forward for managing long-term conditions like cardiovascular disease (CVD). The reduction of both LDL cholesterol and blood pressure is key for managing the risk of CVD. The combination of high blood pressure and cholesterol deposition may lead to the chronic inflammation and hardening of the walls of the blood vessels, which greatly increases the probability of suffering a cardiovascular event. Recent research, presented at the European Society of Cardiology Congress 2016, demonstrated that reducing LDL cholesterol and blood pressure can reduce the lifetime risk of cardiovascular disease by nearly 90%.

The supply agreement grants HLH a non-exclusive license to produce, package, and commercialize products containing the LPLDL strain, and follows HLH’s recent order for 100,000 units of LPLDL. HLH has over 20 years’ experience in the distribution of probiotic and natural products under the brand names Lactobact and Casa Sana and is one of Europe’s leading suppliers of probiotics to the pharmacy market. LPLDL will be supplied as bulk capsules which will be packaged and branded as part of HLH’s market leading Lactobact brand.

Related Articles

Business News

Natural ingredients key for Evonik's growth strategy

23 Aug 2017 --- With an expanding portfolio that includes omega 3 fatty acids and anthocyanin-rich extracts, global specialty chemicals company Evonik Industries is boldly expanding its presence in the Advanced Food Ingredients market. NutritionInsight spoke with Dr. Ludger Eilers, Director of Evonik Health Care’s Food Ingredient Segment, about this move as well as the company’s latest R&D projects and ingredients.

Nutrition & Health News

Plant-based diets associated with lower levels of plasma lipids by meta-analysis

23 Aug 2017 --- Consumption of vegetarian diets, particularly vegan diets, is associated with lower levels of plasma lipids, which could offer individuals and healthcare professionals an effective option for reducing the risk of heart disease or other chronic conditions. This is the finding of a review and meta-analysis by Dr. Yoko Yokoyama, Ms. Susan Levin and Dr. Neil Barnard.

Nutrition & Health News

"Silent" food product reformulation key to helping consumers buy fewer calories

23 Aug 2017 --- Without notifying consumers explicitly, supermarkets could help their customers consume fewer calories by making small changes to the recipes of own-brand food products to reduce the calories contained in the product. This is according to researchers at the University of Copenhagen, who say that so-called “silent” product reformulation may be a promising strategy to allow food retailers to contribute to lower calorie intake in the population.

Food Ingredients News

Nexira Fibregum receives FODMAP friendly certification

23 Aug 2017 --- Natural and organic ingredients company Nexira has announced that its Fibregum product has been certified FODMAP friendly in Australia. The company describes Fibregum as an “all-natural range, with a guaranteed minimum content of 90 percent dietary fibers.” Nexira notes that the FODMAP Friendly program is the only registered certification trademark in the world, making Fibregum’s certification big news for the company. The program’s laboratory tests the FODMAP levels in food and gives the certification to the ones low in FODMAP.

Nutrition & Health News

Adding oats to gluten-free diet is safe for celiac sufferers, study review suggests

23 Aug 2017 --- No evidence has been found by researchers that addition of oats to a gluten-free diet affects symptoms, histology, immunity or serologic features of patients with celiac disease. This is according to a systemic review and meta-analysis of clinical and observational studies.

More Articles
URL : http://www.nutritioninsight.com:80/news/optibiotix-signs-major-supply-agreement-for-its-microbiome-modulating-cholesterol-reduction-probiotic.html